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Background: The role of omega-3 polyunsaturated fatty acids (ω3-PUFAs) in cancer prevention has been
demonstrated; however, the exact molecular mechanisms underlying the anticancer activity of ω3-PUFAs are
not fully understood. Here, we investigated the relationship between the anticancer action of a specific ω3-PUFA
docosahexaenoic acid (DHA), and the conventional mitogen-activated protein kinases (MAPKs) including
extracellular signal-regulated kinase (ERK), c-JUN N-terminal kinase (JNK) and p38 whose dysregulation has
been implicated in human cancers.
Methods: MTT assays were carried out to determine cell viability of cancer cell lines (PA-1, H1299, D54MG and SiHa)
from different origins. Apoptosis was confirmed by TUNEL staining, DNA fragmentation analysis and caspase activity
assays. Activities of the conventional MAPKs were monitored by their phosphorylation levels using immunoblotting
and immunocytochemistry analysis. Reactive oxygen species (ROS) production was measured by flow cytometry and
microscopy using fluorescent probes for general ROS and mitochondrial superoxide.
Results: DHA treatment decreased cell viability and induced apoptotic cell death in all four studied cell lines.
DHA-induced apoptosis was coupled to the activation of the conventional MAPKs, and knockdown of ERK/JNK/p38 by
small interfering RNAs reduced the apoptosis induced by DHA, indicating that the pro-apoptotic effect of DHA is mediated
by MAPKs activation. Further study revealed that the DHA-induced MAPKs activation and apoptosis was associated with
mitochondrial ROS overproduction and malfunction, and that ROS inhibition remarkably reversed these effects of DHA.
Conclusion: Together, these results indicate that DHA-induced MAPKs activation is dependent on its capacity to provoke
mitochondrial ROS generation, and accounts for its cytotoxic effect in human cancer cells.
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Omega-3 polyunsaturated fatty acids (ω3-PUFAs) have the
first double bond in the ω3 position (third carbon from the
methyl end of the carbon chain) and are considered essen-
tial fatty acids because they cannot be synthesized by mam-
mals [1]. These PUFAs are able to regulate eicosanoid* Correspondence: kyulim@cnu.ac.kr
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unless otherwise stated.production [2], transcription events [3], formation of po-
tent lipid peroxidation products [4], Wnt/β-catenin signal-
ing [5,6], and autophagy [7]. Docosahexaenoic acid (DHA)
and eicosapentaenoic acid (EPA) are the main long chain
ω3-PUFAs, and their anticancer effects have been demon-
strated, with DHA showing a stronger effect than EPA be-
cause of the higher degree of unsaturation of the DHA
molecule [8].
Various cellular metabolic processes are associated with
the generation of reactive oxygen species (ROS) including
hydrogen peroxide (H2O2), superoxide anion, and hy-
droxyl radicals as chemically reactive molecules [9]. ROStd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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tor activation, gene expression, and cell differentiation and
proliferation [10]. In mammalian cells, an important
source of ROS generation is the mitochondrial electron
transport chain [11]. Overproduction of ROS induces cel-
lular damage, such as the oxidation of cardiolipin in the
mitochondrial membrane and a decrease in the mitochon-
drial membrane potential (MMP), which leads to apop-
totic cell death [9,11].
ROS activate the mitogen-activated protein kinases
(MAPKs) families, which regulate many cellular processes,
including cell growth, proliferation, differentiation, sur-
vival, and death [12]. Mammals express at least three con-
ventional MAPKs, extracellular signal-regulated kinase
(ERK), c-JUN N-terminal kinase (JNK) and p38, and dys-
regulation of the conventional MAPKs is implicated in
human cancers [13]. While JNK and p38 activation is re-
lated to apoptosis under environmental stress conditions,
especially oxidant injury, the activation of ERK induced by
mitogens, growth factors and cytokines is generally be-
lieved to trigger pro-survival signals [14]. However, recent
studies suggest that ERK activation can also lead to apop-
totic death of tumor cells in repsonse to various antican-
cer agents [15]. For example, cisplatin-induced apoptosis
in human cancer cells has been attributed to ERK activa-
tion, and inhibition of ERK markedly attenuates the pro-
apoptotic effect of cisplatin [16].
In the present study, we investigated the cell death mode
induced by DHA in four cancer cell lines derived from dif-
ferent types of cancers, and explored the relationship be-
tween conventional MAPKs and the cytotoxic effect of
DHA. Our results show that DHA induces apoptotic cell
death via ROS-regulated MAPK activation. These results
have important implications for the chemoprevention and
treatment of human cancer using ω3-PUFAs.
Methods
Chemicals and antibodies
DHA (Cayman Chemical, Ann Arbor, MI, USA) and tetra-
methylrhodamine ethyl ester (TMRE, Invitrogen, Camarillo,
CA, USA) dissolved in absolute ethanol, Dihydroethidium
(DHE, Invitrogen), PD98059 (Calbiochem, Cambridge,
UK), SP600125 (Calbiochem), SB600125 (Calbiochem) and
MitoSOX Red (Invitrogen) dissolved in dimethyl sulfoxide
(Sigma, ST Louis, MO, USA), N-acetyl-L-cystein (NAC,
Sigma) dissolved in phosphate buffered saline and H2O2
(MERCK, Darmstadt, Germany) dissolved in distilled water
were stored at −20°C before use.
The antibodies used and their sources are as follows.
Caspase-3, JNK, p38, phospho-p38 (Thr180/Tyr182) and
XIAP antibodies were purchased from Cell signaling Tech-
nology (Beverly, MA, USA); antibodies against PARP-1/2
(H-250), phospho-ERK (E-4), ERK1 (K-23), Survivin and
actin (I-19)-R were from Santa Cruz (CA, USA); goat anti-rabbit and goat anti-mouse secondary antibodies were from
Calbiochem; and phospho-JNK1&2 (pT183/pY185) anti-
bodies and secondary antibodies (goat anti-rabbit and goat
anti-mouse) conjugated with TRITC were from Invitrogen.
Cell cultures and chemical treatment
Human ovarian cancer PA-1 cells, human lung cancer
H1299 cells, and human cervical cancer SiHa cells were
purchased from American Type Cell Culture Collection
(Rockville, MD, USA). Human glioblastoma D54MG cells
were provided by Dr. Binger (Duke University Medical
Center, Durham, NC, USA). PA-1 cells were maintained
in Minimum Essential Medium (MEM, GIBCO, Grand
Island, NY, USA); H1299 and SiHa cells were maintained
in Dulbecco’s Modified Eagle Medium (DMEM); and
D54MG cells were maintained in RPMI 1640 medium
(GIBCO). The media were supplemented with 10% heat-
inactivated fetal bovin serum (FBS, GIBCO), penicillin
and streptomycin. The cells were cultured in a humidified
5% CO2 atmosphere at 37°C.
Cells grown to 70% confluency were switched into
serum-free media, and the cultures (H1299, D54MG and
SiHa) were allowed to expand for 24 h before giving any
treatment. For PA-1 cells, the serum-free culture condition
was used at 12 h, as an incubation time longer than 12 h
resulted in slight loss of cell viability (data not shown).
Cell viability assay
Cells were plated onto 96-well plates at seeding densities
of 6.5 × 103 cells per well for PA-1, H1299 and SiHa cells
and 7 × 103 cells per well for D54MG cells. The cell via-
bility after treatment with appropriate agents was mea-
sured using Thiazolyl Blue Tetrazolium Bromide (MTT,
Sigma) as previously described [17]. Concentrations of
DHA that produced 50% inhibition in cell survival (IC50)
following a 24 h exposure, were manually derived from
dose–response curves generated by the Microsoft Excel
2010 edition.
Measurement of oxygen consumption rate (OCR)
Cellular oxygen consumption was measured using a Sea-
horse bioscience XF24 analyzer (Seahorse Bioscience
Inc., North Billerica, MA, USA) in 24-well plates at 37°C,
with correction for positional temperature variations
adjusted from four empty wells evenly distributed within
the plate. PA-1 cells were seeded at 4 × 104 cells per well
18 h prior to the analysis, and each experimental condi-
tion was performed on 4 biological replicates. Immedi-
ately before the measurement, cells were switched to 1%
FBS contained MEM for 4 h. Then cells were washed
and 590 μL of non-buffered media (sodium bicarbonate
free, pH 7.4 DMEM) was added to each well. After
15 min equilibration period, three successive 2 min mea-
surements were performed at 3 min intervals with inter-
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tion in the medium and each condition was measured
in independent walls. Concentrated compounds (10X)
were injected into each well using the internal injector
of the cartridge and three successive 2 min measure-
ments were performed at 3 min intervals with inter-
measurement mixing.
Western blot, immunocytochemistry and apoptosis assays
Western blot, immunocytochemistry and apoptosis as-
says were done as described previously in reference [7].
Determination of intracellular ROS and MMP
ROS production was measured using fluorescent probes
DHE, and MitoSOX. Cells seeded onto 6-well plates
were first stained with either DHE (10 μM) or MitoSOX
(5 μM) in Hanks’ balanced salt solution (HBSS) for
30 min (15 min in case of MitoSOX) at 37°C. After
washing away unbound probes, cells were switched into
serum-free media, pretreated with or without 5 mM of
NAC for 1 h and exposed to DHA for 4 h. Direct im-
aging of ROS in probe-stained cells was performed using
a fluorescence microscope (Olympus iX70, Japan), and
images were captured with a DP Controller software. All
images were taken under identical exposure conditions
to assess the intensity of the probe fluorescence accur-
ately. Alternatively, the probe-stained cells were de-
tached with trypsin-EDTA, washed and fluorescence
intensity was measured within 60 min by flow cytome-
try. For each sample, at least 10,000 events were ac-
quired and analyzed using the BD FACS-Calibur (BD
Bioscience, San Diego, CA, USA). MMP levels were
evaluated using fluorescent probes, TMRE. In brief, cells
were stained with TMRE at a concentration of 25 nM
for 15 min at 37°C in HBSS, washed twice, and then pre-
incubated with or without 5 mM of NAC for 1 h in
serum-free media before DHA exposure. After incuba-
tion with DHA for 4 h, the fluorescence of the cells
stained with TMRE was monitored by flow cytometry as
described above.
Small interfering RNAs (siRNAs)
siRNAs for human ERK1/2, JNK1/2 and p38 were pur-
chased from Bioneer (Daejeon, Korea). For transfection,
25 nM siRNAs were added to 9 × 105 cells in a 100 mm
dish using Lipofectamine RNAiMAX (Invitrogen) as rec-
ommended by the vendor. Control cells were transfected
with a negative control siRNA with no known mRNA
target (5’-ACG UGA CAC GUU CGG AGA AUU-3’)
designed by Bioneer. After 18 h of transfection, cells
were switched into serum-free media for 24 h (12 h in
case of PA-1 cells) and then treated with DHA. The siR-
NAs sequences used were: ERK1 (5′-GAC CGG AUG
UUA ACC UUU A-3′), ERK2 (5′-CCA AAG CUC UGGACU UAU-U-3′), JNK1 (5′-CUG GUA UGA UCC UUC
UGA A-3′), JNK2 (5′-CUG UAA CUG UUG AGA UGU
A-3′) and p38 (5′-CAA AUU CUC CGA GGU CUA A -3′).
Statistical analysis
Student’s t test was performed for statistical analyses.
In all analyses, the level of statistical significance was
more than the 95% confidence level (P < 0.05). *** means
P < 0.001.
Results
DHA inhibits cell viability and induces apoptosis in
human cancer cells
To examine the effect of DHA on the growth of human
cancer cells, PA-1, H1299, D54MG and SiHa cells originat-
ing from ovarian, lung, brain and cervical tumors were cul-
tured with increasing concentrations (0–60 μM) of DHA
for up to 48 h, and the cell viability was measured by MTT
assays. DHA reduced cell viability in a dose- and time-
dependent manner in all four cell lines studied (Additional
file 1: Figure S1A). Figure 1A shows the viability and IC50
values of the cells after multiple doses of DHA exposure for
24 h. Four cell lines exhibited different sensitivity to DHA,
and the IC50 values for PA-1, H1299, D54MG and SiHa
cells were 15.485 ± 3.08, 26.914 ± 3.68, 27.136 ± 4.26 and
23.974 ± 3.82 μM, respectively.
To determine whether the observed reduction in cell
viability was caused by apoptosis, DHA-treated cells were
first examined for cleavage of the apoptosis marker PARP
and expression levels of Bcl-2 family proteins, which play
critical roles in the apoptotic process [18]. While DHA
increased the expression levels of cleaved PARP and pro-
apoptotic Bax, it attenuated the expression level of anti-
apoptotic Bcl-2 (Figure 1B). In addition, DHA induced
the formation of DNA strand breaks/hypodipliod nuclei
(a typical characteristic of apoptotic cells [18]) as evi-
denced by an increased number of TUNEL positive cells
(Figure 1C) and the cells with Sub-G1 DNA content
(Figure 1D and Additional file 2: Figure S2). Notably, the
elevated Sub-G1 population was directly paralleled by di-
minished proportions of D54MG (Figure 1D) and PA-1
cells (Additional file 2: Figure S2A) in each cell-cycle
phase. However, a transient increase in the cell popula-
tions in G2/M phase was detected 6 h after 30 μM DHA
treatment in H1299 and SiHa cell lines (Additional file 2:
Figure S2B-S2C), implying that DHA may also interfere
with cell-cycle distribution. Next, we measured the activity
and cleavage formation of caspase-3, an executor cas-
pase that is activated through both intrinsic and extrin-
sic apoptosis pathways [18], using PA-1 cells. Our
results showed that DHA dose-dependently activated
caspase-3 (Figure 1E, left), and upregulated the level of
cleaved caspase-3 (Figure 1E, right and Additional file 1:
Figure S1B). It is known that the inhibitor of apoptosis
Figure 1 DHA reduces viability and induces apoptotic death of human cancer cells. (A) DHA dose-dependently decreases the viability of
PA-1, H1299, D54MG and SiHa cells. Cells were treated with the indicated doses of DHA for 24 h, and the cell viability was measured with MTT
assays as described in the Materials and Methods. Each bar represents the mean of three determinations repeated in three separate experiments.
(B) DHA induces apoptosis. Human cancer cells were incubated with DHA at the indicated doses, and cells were harvested and western blot
analysis was performed using PARP, Bax, Bcl-2 and actin antibodies. (C) D54MG cells were incubated for 6, 12, 24 h with indicated doses of DHA,
and Sub-G1 DNA contents were evaluated by flow cytometric analysis. Samples were analyzed using FlowJo software. (D) DHA increases the
number of TUNEL positive PA-1 cells. Cells were plated on coverslips, and incubated with or without DHA for 6 h. The cells were stained with
DeadEnd Fluorometric TUNEL system. Left, the results are shown as a microscopy image. DNA was counterstained with DAPI (scale bar, 200 μm).
Right, the percentage of TUNEL positive cells treated with or without DHA was calculated relative to the total number of DAPI-stained nuclei.
TUNEL positive cells were counted in three different fields and averaged. ***, P < 0.001. (E) Increases in caspase-3 activities and caspase-3 cleavage
formation by DHA. PA-1 cells were treated with various concentrations of DHA for 12 h and lysed. Left, Caspase-3 activity was determined using
the fluorogenic substrate DEVD-AFC. Values are mean ± SEM (n = 5). ***, P < 0.001. Right, western blot analysis of cleaved caspase-3, XIAP and
Survivin. Equal loading of protein lysate was confirmed using an anti-actin antibody.
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ting caspase-3 [19]. We thus also determined the effect of
DHA on expression of two well-documented IAP family
members, Survivin and XIAP (Figure 1E, right). Levels of
Survivin and XIAP were decreased markedly after DHA
treatment. These results indicate that DHA induces apop-
tosis, which contributes to the inhibitory effect of DHA
on cancer cell growth.
DHA leads to MAPK activation
Conventional MAPKs play important roles during can-
cer progression, and have been shown to be activated
during the apoptotic death of tumor cells in response to
various cellular stresses [13-15,20]. To gain insights intothe mechanisms by which DHA induces apoptosis in
cancer cells, we first investigated whether DHA treat-
ment resulted in the activation of conventional MAPKs.
Immunoblotting revealed that DHA, used at concenta-
rions triggering apoptosis, remarkably elevated the phos-
phorylation levels of ERK/JNK/p38 in all four cell lines
(Figure 2A). The phosphorylation of ERK and p38 be-
came apparent at relatively earlier time points tested
(0.5-3 h) following treatment of PA-1 cells with 40 μM
DHA (Figure 2B). Additionally, a rapid and transient
increase in ERK phosphorylation was observed after
15 min of treatment, which is in line with ERK activa-
tion being an indicator of stress [21]. Because MAPK
signaling involves the activation of transcription factors
Figure 2 DHA activates MAPKs. (A) DHA induces MAPKs activation. PA-1, H1299, D54MG and SiHa cell lines were treated with the indicated
doses of DHA for and 24 h (12 h in case of PA-1 cells). Then, protein lysates were separated and immunoblotted with antibodies against
conventional MAPKs. (B) Expression patterns of conventional MAPKs in response to DHA over time. PA-1 cells treated with 40 μM DHA for the
indicated time periods were subjected to immunoblotting for MAPKs. (C-E) Nuclear accumulation of phospho-ERK, −JNK, and -p38 in PA-1 cells
after DHA exposure. PA-1 cancer cells were incubated for 6 h with or without 40 μM DHA. Then, cells were stained with antibodies against
phospho-ERK (C), phospho-JNK (D) and phospho-p38 (E) and analyzed by immunoflurescence. Scale bars, 50 μm.
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termine whether the activation of MAPKs was accompan-
ied by their accumulation in nuclei. Figure 2C-E show
that the fluorescence intensity of phospho-ERK, −JNK,
and -p38 was increased in DHA-treated cells. Further-
more, DHA also increased the number of cells with
nuclear staining for these phosphorylated MAPKs.
These data together indicate that DHA activates the
conventional MAPKs in cancer cells.
DHA induces mitochondrial ROS production
ROS are potent regulators of MAPK activity [10,12], we
therefore examined the potential involvement of ROS
production in DHA-induced MAPKs activation. The
effect of DHA on the production of superoxide wasexamined by monitoring DHE fluorescence. DHA treat-
ment increased intracellular superoxide levels, and treat-
ment with the antioxidant NAC blocked intracellular
superoxide production in PA-1 cell line (Figure 3A).
Since mitochondria are the main source of ROS in
mammalian cells [11], we asked whether DHA-induced
ROS were derived from mitochondria by measuring
mitochondrial ROS production using the MitoSOX
probes. The results (Figure 3B-C) showed that DHA
enhanced the mitochondrial superoxide levels, and
anoxidants NAC effectively blocked this effect of DHA,
indicating that DHA induces ROS overproduction, in
particular that of mitochondrial superoxide. Excessive
mitochondrial ROS generation is associated with changes
in mitochondrial function [22]. To ensure our above
Figure 3 DHA induces mitochondrial ROS overproduction and mitochondrial dysfunction. (A-B) PA-1 cells were incubated for 1 h with or
without 5 mM NAC before exposure to 40 μM DHA for 4 h. Intracellular superoxide and mitochondrial superoxide levels were detected using
DHE (A) or MitoSOX (B) probes under a fluorescence microscope (right) or by flow cytometry (left), as described in Meterial and Methods (scale
bar, 50 μm). (C) MitoSOX-stained H1299 and SiHa cells were exposed to 60 μM (50 μM in case of D54MG cells) DHA with 1 h of 5 mM NAC
pretreatment. After 4 h of DHA exposure, the fluorescence of MitoSOX-stained cells were observed by fluorescence microscopy (scale bar, 50 μm).
(D) DHA reduces MMP. PA-1 cells were stained with 25 nM TMRE, exposed to 5 mM NAC for 1 h and then DHA was added into the media
followed by a further 4 h incubation. MMP was assayed by flow cytometry analysis (left). Right, data are presented as the average mean intensity
fluorescence (MFI). ***, P < 0.001. Each bar represents the mean of three determinations repeated in three separate experiments. (E) Decrease
in OCR by DHA treatment. PA-1 cells were seeded in 24-well XF analysis plates, and treated with 40 μM of DHA with 1 h of 5 mM NAC
pretreatment. The OCR was monitored for 2 h, and calculated relatively to the vehicle control and average of five wells is shown.
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mitochondrial ROS is accompanied by mitochondrial dys-
function, we examined the MMP, which is an index of
mitochondrial function [22], by labeling mitochondria
with TMRE. As shown in Figure 3D, TMRE staining inten-
sity decreased dramatically in response to DHA treatment.
Furthermore, NAC treatment almost completely restored
the decreases in TMRE intensity induced by DHA. The
DHA-induced mitochondrial malfunction was further
confirmed by measuring OCR (i.e., mitochondrial respi-
ration rate). DHA remarkably decreased OCR, and NAC
partially reversed this inhibitory effect of DHA (Figure 3E),
suggesting that DHA-induced mitochondrial ROS produc-
tion indeed impairs the function of mitochondria. Takentogether, these results imply that mitochondrial ROS
contributes to the increased level of cellular ROS
induced by DHA.
DHA-induced MAPKs activation is required for apoptosis
To unveil the role of MAPKs activation in DHA-
induced apoptotic cell death, H1299 cells were first ex-
posed to DHA in the absence or presence of the MAPK
inhibitors PD98059, SP600125 and SB202190, specific
for ERK, JNK and p38, respectively. The level of apop-
tosis was monitored by westernblotting using antibodies
against PARP. As shown in Figure 4A, PD98059, SP600125
and SB202190 decreased the protein levels of cleaved PARP
induced by DHA. These results suggest that the activation
Figure 4 Activation of MAPKs is responsible for the apoptosis induced by DHA. (A) Indicated MAPKs inhibitors were added to H1299
cells 1 h before DHA treatment for 24 h. The protein levels of PARP and MAPKs were then examined by western blot. (B) Indicated cancer cells
were treated with non-targeting control siRNA (siNC) or siRNAs specific for conventional MAPKs genes (siERK, siJNK and sip38). At 18 h after
transfection, cells were incubated with the indicated doses of DHA for 24 h (12 h in cases of PA-1 cells). Then, cells were harvested and western
analysis was performed using the following antibodies: PARP, MAPKs and actin. The data shown are representative of three independent
experiments with similar results.
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apoptosis. The effects of the MAPKs on DHA-induced
apoptosis were further examined by siRNA mediated
knockdown of ERK, JNK and p38. Compared to cells
treated with control siRNA, knockdown of three conven-
tional MAPKs decreased the DHA-induced apoptosis in
all four cell lines, as revealed by the level of cleaved PARP
(Figure 4B), confirming that inactivation of the conven-
tional MAPKs diminishes the DHA-dependent induction
of apoptosis in cancer cells.
DHA-induced ROS production is responsible for the
MAPKs activation
Next, we sought to determine the relationship between
excessive ROS generation and apoptotic cell death in-
duced by DHA. To this end, PA-1 cells were first treated
with 40 μM DHA in the presence and absence of NAC,
and the levels of cell death were examined by MTT as-
says and flow cytometry. DHA dramatically decreased
the number of viable cells (Figure 5A, left) and increased
the Sub-G1 cell population (Figure 5A, right), which
could be partially reversed by NAC, suggesting thatDHA-induced apoptosis may be attributed to its capacity
to trigger ROS overproduction. As our data suggested
that the DHA-induced apoptosis was associated with
excessive ROS production and MAPK activation, we
investigated the possible link between apoptosis, ROS
and MAPK. We found that the DHA-induced increases
in cleaved PARP and phospho-MAPKs levels were
remarkably attenuated by NAC pretreatment in all four
tested cancer cell lines (Figure 5B). The effect of NAC
on DHA-induced MAPKs activation was confirmed by
immunocytochemistry assays. As shown in Additional
file 3: Figure S3A-S3C, DHA increased both cytoplasmic
and nuclear phospho-ERK, −JNK, and -p38 levels, whereas
NAC reduced these effects of DHA. These data suggest
that excessive cellular ROS accumulation contributes
to the DHA-induced conventional MAPKs activation
and apoptosis.
To verify the above findings, we used a different
approach. PA-1 cells were first treated with exogenous
ROS, H2O2, in the presence or absence of NAC. Then, cell
viability and the levels of cleaved PARP and phospho-
MAPKs were analyzed by MTT assays (Figure 5C, top)
Figure 5 Excessive ROS is associated with activation of MAPKs and subsequent apoptosis induced by DHA. (A) DHA-induced ROS
production is required for apoptosis. PA-1 cells were exposed to 40 μM DHA in the presence or absence of 5 mM NAC for 12 h. Left, cell viability
was determined by the MTT assay. ***, P < 0.001. Each bar represents the mean of three determinations repeated in three separate experiments.
Right, cells were collected to examine the percentage of cells in Sub-G1 phase by flow cytometry analysis. Samples were analyzed using FlowJo
software. (B) NAC blocks the DHA-induced MAPKs activation. PA-1, H1299, D54MG and SiHa cell lines were incubated for 1 h with or without
5 mM NAC before exposure to the indicated doses of DHA for and 24 h (12 h in case of PA-1 cells). After cell lysis, PARP and MAPKs protein levels
were examined by western blot analysis. (C) Apoptosis and MAPK activation in response to exogenous ROS, hydrogen peroxide. PA-1 cells were
pretreated with or without 5 mM NAC for 1 h, followed by 300 μM hydrogen peroxide exposure for 12 h. Cell viability and the expression levels
of cleaved PARP and MAPK were assessed by MTT assays (upper) and western blot analysis (lower). ***, P < 0.001.
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H2O2 decreased cell viability and increased the expression
levels of cleaved PARP as well as phospho-MAPKs; and
NAC remarkably reversed these effects of H2O2. Further-
more, H2O2 also significantly increased the nuclear stain-
ing levels of phospho-ERK/JNK/p38, which could be
prevented by NAC pretreatment (Additional file 3: Figure
S3D-S3F). Together, these findings demonstrated that
excessive ROS production is responsible for the activation
of MAPKs, and that DHA-induced apoptosis is linked to
the ROS-mediated MAPKs activation in cancer cells.
Discussion
The ω3-PUFA, DHA prevents cancer through regulating
multiple targets implicated in various stages of cancer
progression, and one aspect of its antitumor effect in-
volves inhibition of cell growth [1]. It has been shown
that the growth-inhibitory effect of DHA is attributed toapoptosis and/or cell-cycle arrest, depending on the cell
line studied [23,24]. In agreement with this, our results
showed that the apoptosis induced by DHA is accompan-
ied by cell-cycle arrest in H1299 and SiHa cells but not
in PA-1 and D54MG cells. Although the identification of
molecular determinant controlling either apoptosis or
cell-cycle arrest as alternative modes of DHA-induced
growth inhibition requires further investigation, these in-
consistent observations indicate that detailed mechanistic
events underlying the growth-inhibitory effect of DHA
may be also cell type specific.
One major finding of this study is that the activation
of conventional MAPKs (ERK, JNK and p38) is critical
for the induction of apoptosis in tumor cells exposed to
DHA. This finding confirms the results from previous
studies [25-27], showing that DHA-induced apoptosis
involves p38 activation. Meanwhile, it extends these
studies by demonstrating that ERK and JNK activation is
Figure 6 Schematic model of DHA-induced apoptosis in human
cancer cells. The DHA-induced apoptosis was dependent on its
ability to trigger excessive mitochondrial ROS generation and
subsequent conventional MAPKs activation.
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DHA. The detailed mechanism by which activation of
conventional MAPKs promotes DHA-induced apoptosis
is still uncertain. We found that the apoptosis triggered
by DHA was associated with altered protein levels of
Bax and Bcl-2. Since conventional MAPKs activation
has been shown to promote the expression and phos-
phorylation of pro-apoptotic Bax, and to disrupt anti-
apoptotic Bcl-2 function, thereby resulting in apoptosis
[20,28,29], it is reasonable to assume that Bax and Bcl-2
may act downstream of MAPKs activation to induce
apoptosis in tumor cells treated with DHA. Notably, our
data contrast with the findings of previous studies [30-33]
which show that inactivation of ERK/p38 by DHA
accounts for the apoptotic death of MCF-7, A549 and
HCT-116 cancer cells. The reason for such disparate regu-
lation of MAPKs activity in response to DHA is unclear,
but might be related to the distinct genetic background
(e.g., the prodeath or prosurvival role of basal MAPKs
activity) of different types of cancer cells [13,14].
Previous studies suggest that the apoptosis inducing
effect of DHA is at least partially attributed to its cap-
acity to trigger mitochondrial ROS overproduction and
malfunction [1,4,17,34]. Mitochondria are the major cel-
lular organelles producing ROS and within mitochon-
dria, the primary site of ROS generation is electron
transport chain [11]. Therefore, our results that upon
DHA exposure, the ROS, especially mitochondrial super-
oxide overproduced, and the OCR dramatically decreased
with an increase in extracellular acidification rate (Figure 3
and data not shown), implying that DHA may cause a
metabolic shift from oxidative phosphorylation to glycoly-
sis and the disruption of electron transport chain.
Another question we addressed in the present study is
the relationship between ROS, MARKs activation and
apoptosis induced by DHA. ROS mediate MAPKs and
the ROS-regulated ERK/JNK/p38 signaling in governing
apoptosis under oxidative conditions have been widely
investigated [10]. Although many studies have provided
a general view that activation of the ERK pathway delivers
a survival signal under oxidative stress, which counteracts
the pro-apoptotic signaling associated with JNK and p38
activation [14], it is also reported that ROS-mediated ERK
activation can induce apoptosis [15]. Our observations
that DHA induced conventional MAPKs activation and
apoptosis, which could be blocked by antioxidants are
in agreement with the view that ROS-mediated activation
of ERK/JNK/p38 in DHA-treated cancer cells is pro-
apoptotic. Then, how do DHA-induced ROS result in the
simultaneous activation of ERK/JNK/p38? One of poten-
tial molecules that may mediate this process is ASK1
(apoptosis signal-regulating kinase 1). ASK1 is substan-
tially activated in response to a variety of ROS inducers,
and has been shown to induce the activation of not onlyp38, but also ERK and JNK [35,36]. Thus, it is foreseen
that DHA-induced ROS would simultaneously activate all
three conventional MAPKs via upregulation of ASK1.
Conclusions
To summarize, the ω3-PUFA, DHA induces apoptotic
cell death in various cancer cell lines. This increased
apoptosis induced by DHA is dependent on its ability to
trigger excessive mitochondrial ROS generation and
subsequent conventional MAPKs activation (Figure 6).
Thus, DHA may serve as an effective agent for the treat-
ment and chemoprevention of human cancers.
Additional files
Additional file 1: Figure S1. DHA induces apoptosis. (A) DHA reduces
cell viability in dose- and time dependent manner in PA-1, H1299,
D54MG and SiHa cells. Cells were treated with the indicated doses of
DHA for 0, 6, 12, 24 and 48 h. Cell viability was measured with the MTT
assays as described in the Materials and Methods. IC50 values of DHA
for four cell lines at exposure duration of 24 h were shown. Each bar
represents the mean of three determinations repeated in three separate
experiments. (B) DHA time-dependently induces apoptosis. PA-1 cells
were treated with 40 μM DHA for the indicated time, and cleaved
PARP as well as caspase-3 protein levels were detected by western
blot analysis.
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http://www.biomedcentral.com/1471-2407/14/481Additional file 2: Figure S2. The growth-inhibitory effect of DHA is cell
type specific. PA-1 (A), H1299 (B) and SiHa (C) cells were exposed to
increasing concentrations of DHA for 6, 12 and 24 h, and cell cycle was
measured by FACS analysis. Samples were analyzed using FlowJo
software. The data shown are representative of three independent
experiments with similar results.
Additional file 3: Figure S3. Generated ROS by DHA increases MAPKs
activation. (A-C) PA-1 cells were first incubated with 5 mM NAC for 1 h;
then indicated doses of DHA were added and the cells were incubated
for 6 h. Cells were stained with antibodies against phospho-ERK (A),
phospho-JNK (B), and phospho-p38 (C) and analyzed by the
immunofluorescence assay (scale bar, 100 μm). (D-F) Hydrogen peroxide
enhances MAPKs activation. PA-1 cells were first exposed to 5 mM
NAC for 1 h; then 300 μM hydrogen peroxide was added and the cells
were incubated for 6 h. Cells were immunofluorescently stained with
antibodies against phospho-ERK (D), phospho-JNK (E), and phospho-p38
(F) (scale bar, 100 μm).
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